HomeXSPRAY • STO
add
XSpray Pharma AB (publ)
Previous close
kr 48.85
Day range
kr 47.15 - kr 49.85
Year range
kr 22.59 - kr 63.67
Market cap
1.94B SEK
Avg Volume
67.02K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 42.32M | -21.35% |
Net income | -44.86M | 16.28% |
Net profit margin | — | — |
Earnings per share | -2.35 | -43.29% |
EBITDA | -40.93M | 20.46% |
Effective tax rate | 0.06% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 73.81M | -41.69% |
Total assets | 696.98M | -5.31% |
Total liabilities | 161.53M | 137.78% |
Total equity | 535.45M | — |
Shares outstanding | 37.14M | — |
Price to book | 3.39 | — |
Return on assets | -14.75% | — |
Return on capital | -15.46% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -44.86M | 16.28% |
Cash from operations | -44.11M | 31.27% |
Cash from investing | -6.13M | 29.82% |
Cash from financing | -1.31M | -101.38% |
Net change in cash | -51.92M | -331.59% |
Free cash flow | -34.05M | 34.88% |
About
Founded
2003
Website
Employees
26
